Logo image of APLS

APELLIS PHARMACEUTICALS INC (APLS) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:APLS - US03753U1060 - Common Stock

24.68 USD
+0.9 (+3.78%)
Last: 12/10/2025, 8:00:01 PM
24.68 USD
0 (0%)
After Hours: 12/10/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
APLS revenue by date.APLS revenue by date.
75.4M
13.21%
396.591M
425.98%
781.367M
97.02%
1.008B
29.00%
884.42M
-12.26%
1.067B
20.64%
1.281B
20.06%
1.492B
16.47%
1.7B
13.94%
1.789B
5.24%
1.945B
8.72%
EBITDA
YoY % growth
APLS ebitda by date.APLS ebitda by date.
-593.05M
-10.87%
-515.337M
13.10%
-163.182M
68.33%
86.227M
152.84%
-82.165M
-195.29%
81.482M
199.17%
235.19M
188.64%
394.6M
67.78%
669.86M
69.76%
763.48M
13.98%
1.025B
34.25%
EBIT
YoY % growth
APLS ebit by date.APLS ebit by date.
-594.6M
-10.87%
-517.121M
13.03%
-164.979M
68.10%
67.468M
140.89%
-108.327M
-260.56%
22.987M
121.22%
154.7M
572.99%
316.62M
104.67%
484.08M
52.89%
670.72M
38.56%
789.56M
17.72%
Operating Margin
APLS operating margin by date.APLS operating margin by date.
-788.59%-130.39%-21.11%6.69%-12.25%2.15%12.08%21.22%28.48%37.49%40.59%
EPS
YoY % growth
APLS eps by date.APLS eps by date.
-6.13
31.35%
-4.48
26.92%
-1.45
67.63%
0.27
118.29%
-1.12
-522.82%
-0.07
93.98%
0.85
1,365.69%
1.88
120.76%
3.12
65.74%
3.50
12.11%
3.95
12.67%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.38
-30.65%
-0.46
37.22%
-0.33
-0.03%
-0.26
-115.77%
-0.14
63.99%
-0.09
80.24%
0.21
164.89%
0.33
223.94%
0.46
436.45%
Revenue
Q2Q % growth
204.8M
-3.64%
194.78M
16.78%
214.02M
19.90%
226.89M
-50.52%
263.38M
28.60%
265.4M
36.26%
310.3M
44.99%
330.68M
45.74%
357.6M
35.77%
EBITDA
Q2Q % growth
-43.826M
-79.86%
-61.486M
25.81%
-45.834M
-41.49%
-30.159M
-113.44%
-2.009M
95.42%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-42.863M
-63.83%
-52.558M
36.93%
-39.794M
-19.55%
-28.167M
-112.62%
-12.798M
70.14%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
1.67
463.04%
1.210.4638.10%
Q2 2025
Q2Q % growth
-0.33
-17.86%
-0.480.1531.03%
Q1 2025
Q2Q % growth
-0.74
-76.19%
-0.37-0.37-101.36%
Q4 2024
Q2Q % growth
-0.29
60.27%
-0.390.1026.26%
Q3 2024
Q2Q % growth
-0.46
60.68%
-0.31-0.15-50.27%
Q2 2024
Q2Q % growth
-0.28
72.55%
-0.330.0515.16%
Q1 2024
Q2Q % growth
-0.42
73.08%
-0.480.0611.77%
Q4 2023
Q2Q % growth
-0.73
51.33%
-0.70-0.03-4.28%
Q3 2023
Q2Q % growth
-1.17
33.14%
-0.87-0.30-34.09%
Q2 2023
Q2Q % growth
-1.02
30.14%
-1.350.3324.40%
Q1 2023
Q2Q % growth
-1.56
-9.86%
-1.49-0.07-4.46%
Q4 2022
Q2Q % growth
-1.50
6.83%
-1.600.106.20%
Q3 2022
Q2Q % growth
-1.75
23.25%
-1.48-0.27-17.99%
Q2 2022
Q2Q % growth
-1.46
46.32%
-1.39-0.07-4.87%
Q1 2022
Q2Q % growth
-1.42
38.79%
-1.35-0.07-5.49%
Q4 2021
Q2Q % growth
-1.61
-273.12%
-1.57-0.04-2.63%
Q3 2021
Q2Q % growth
-2.28
-27.37%
-1.73-0.55-31.79%
Q2 2021
Q2Q % growth
-2.72
-73.25%
-1.72-1.00-58.19%
Q1 2021
Q2Q % growth
-2.32
-1.31%
-1.62-0.70-43.34%
Q4 2020
Q2Q % growth
0.93
152.54%
-0.771.70221.15%
Q3 2020
Q2Q % growth
-1.79
-62.73%
-1.61-0.18-11.07%
Q2 2020
Q2Q % growth
-1.57
-40.18%
-1.36-0.21-15.26%
Q1 2020
Q2Q % growth
-2.29
-163.22%
-1.41-0.88-62.50%
Q4 2019
Q2Q % growth
-1.77 -1.16-0.61-52.18%
Q3 2019
Q2Q % growth
-1.10 -1.03-0.07-6.56%
Q2 2019
Q2Q % growth
-1.12 -0.79-0.33-42.20%
Q1 2019
Q2Q % growth
-0.87 -0.68-0.19-27.65%
APLS Yearly EPS VS EstimatesAPLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 -4 -6 -8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
458.578M
132.98%
414.81M43.768M10.55%
Q2 2025
Q2Q % growth
178.494M
-10.61%
192.29M-13.796M-7.17%
Q1 2025
Q2Q % growth
166.797M
-3.21%
199.52M-32.723M-16.40%
Q4 2024
Q2Q % growth
212.528M
45.19%
202.32M10.208M5.05%
Q3 2024
Q2Q % growth
196.83M
78.29%
204.36M-7.53M-3.68%
Q2 2024
Q2Q % growth
199.685M
110.26%
194.9M4.785M2.46%
Q1 2024
Q2Q % growth
172.325M
284.26%
166.62M5.705M3.42%
Q4 2023
Q2Q % growth
146.377M
544.83%
146.47M-93K-0.06%
Q3 2023
Q2Q % growth
110.399M
399.54%
101.04M9.359M9.26%
Q2 2023
Q2Q % growth
94.969M
482.63%
71.657M23.312M32.53%
Q1 2023
Q2Q % growth
44.846M
211.43%
26.625M18.221M68.44%
Q4 2022
Q2Q % growth
22.7M
-62.35%
24.921M-2.221M-8.91%
Q3 2022
Q2Q % growth
22.1M
287.72%
22.025M75K0.34%
Q2 2022
Q2Q % growth
16.3M
2,616.67%
17.283M-983K-5.69%
Q1 2022
Q2Q % growth
14.4M 12.824M1.576M12.29%
Q4 2021
Q2Q % growth
60.3M
-75.88%
8.96M51.34M572.99%
Q3 2021
Q2Q % growth
5.7M
850.00%
7.37M-1.67M-22.66%
Q2 2021
Q2Q % growth
600K 509.918K90.082K17.67%
Q1 2021
Q2Q % growth
2.318M-2.318M-100.00%
Q4 2020
Q2Q % growth
250M 98.008M151.992M155.08%
APLS Yearly Revenue VS EstimatesAPLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-8.56% -29.05% 1186.5% 133.58%
Revenue-1.76% -5.96% 2.88% 6.98%